GLP-1 diabetes drugs linked to increased risk of hair loss - BMJ Group

Unsure

bmjgroup.comby Hannah AhmedJuly 23, 2026Submitted July 26, 2026

Absolute risk low, but findings may help inform treatment decisions, say researchers Use of glucagon-like peptide-1 (GLP-1) receptor agonists used to treat type 2 diabetes and obesity are associated with an increased risk of hair loss (alopecia) in adults with type 2 diabetes, finds a study published by The BMJ today. Although the absolute risk is low, awareness of

The Verdict

ClassificationUnsure

ConfidenceHigh confidence

Analyzedtext, image

ImageAI Generated

Community Verdict

Be the first to vote on this assessment.

Embed Badge

Add this badge to your site to show the AI classification for this content.

[![Real Press](https://real.press/api/badge/2c494a26-27a5-4755-b707-5d3400af9294)](https://real.press/content/2c494a26-27a5-4755-b707-5d3400af9294)